Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2025-01-29 00:00:00 ET · period of report 2025-01-27 · accession 0000897069-25-000130 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-01-29 | 2025-01-27 | PCSA | Lin Patrick | Chief Business - Strategy Off | P - Purchase | $0.8 | +43.5K | 43.5K | New | +$34.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-27 | P | A | 43,500 | $0.8 | 43,500 | I Lin Family Trust Feb 4, 2024 | — | — |